Review the side-effects of Risankizumab as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the instances these side-effects are mild and easily tolerable, however sometimes they can be more severe and can be detrimental.
If the side effects are not tolerable adjusting the dosage or switching to a different medication can help to manage or overcome side effects. If you have any doubts or questions, we recommend seeking advice from your doctor or pharmacist. 1.Respiratory system: Respiratory tract infections, sinusitis, rhinitis (running nose), nasopharyngitis, pharyngitis, tonsillitis
2.Central nervous system: Tension headache, sinus headache.
3.General: Fatigue, injection site pain, redness, leakage of blood, infection, swelling, pruritus (itching) etc.
2.Evaluate patients for tuberculosis before initiating treatment with Risankizumab.
3.Avoid administration of live vaccines during the treatment with Risankizumab.
4.Patients who are pregnant, lactating should consult health care provider before starting the therapy.
5.Elder patients aged above 75 years and adolescents below 18 years should consult health care provider before starting the therapy.
If the side effects are not tolerable adjusting the dosage or switching to a different medication can help to manage or overcome side effects. If you have any doubts or questions, we recommend seeking advice from your doctor or pharmacist. 1.Respiratory system: Respiratory tract infections, sinusitis, rhinitis (running nose), nasopharyngitis, pharyngitis, tonsillitis
2.Central nervous system: Tension headache, sinus headache.
3.General: Fatigue, injection site pain, redness, leakage of blood, infection, swelling, pruritus (itching) etc.
Other Precautions :
1.Risankizumab may increase the chance of infections. If an infection develops, do not start Risankizumab until the infection resolves.2.Evaluate patients for tuberculosis before initiating treatment with Risankizumab.
3.Avoid administration of live vaccines during the treatment with Risankizumab.
4.Patients who are pregnant, lactating should consult health care provider before starting the therapy.
5.Elder patients aged above 75 years and adolescents below 18 years should consult health care provider before starting the therapy.